Evidence map›Paper›PMID 36722048›Full record

ArticleThe Journal of infectious diseases2023

Now is the Time to Scale Up Birth-Dose Hepatitis B Vaccine in Low- and Middle-Income Countries.

Peyton Thompson, Jonathan B Parr, Alix Boisson, Devin Razavi-Shearer, Oliver C Ezechi, Su H Wang, Joseph D Tucker

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Hepatitis B Elimination Globally: The Answer May Not Be the Same for Everyone.Journal of the Pediatric Infectious Diseases Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Peyton ThompsonDepartment of Pediatrics, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-9679-9763
Jonathan B ParrDepartment of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Alix BoissonDepartment of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Devin Razavi-ShearerCenter for Disease Analysis Foundation, Lafayette, Colorado, USA.
Oliver C EzechiCentre for Reproductive and Population Health Studies, Nigerian Institute of Medical Research, Lagos, Nigeria.
Su H WangWorld Hepatitis Alliance, London, United Kingdom.
Joseph D TuckerDepartment of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Funding

Characterizing Hepatitis B Transmission in Congolese ChildrenK08AI148607 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMPSON, PEYTON J · 2020 to 2024
$1.0M
NIAID NIH HHS K08 AI148607
6 · The paper itself

Abstract

Fewer than half of the world's infants have access to the birth dose of hepatitis B vaccine (HBV), which prevents mother-to-child transmission of HBV and subsequent liver cancer. Now is the time to expand access for infants born in low-resource settings.

Indexed as

Hepatitis BLiver NeoplasmsPregnancy Complications, InfectiousDeveloping CountriesFemaleHepatitis B Surface AntigensHepatitis B VaccinesHepatitis B virusHumansInfantInfectious Disease Transmission, VerticalPregnancyHepatitis B Surface AntigensHepatitis B Vaccinesglobal health equityHepatitis Bprevention of mother-to-child transmissionvaccination

Identifiers

PMID36722048
PMCPMC10686687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.